PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 12 '26 | Option Exercise | 0.00 | 17,666 | 0 | 58,057 | Jan 12 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 12 '26 | Sale | 22.67 | 9,560 | 216,759 | 48,497 | Jan 12 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 05 '26 | Option Exercise | 0.00 | 37,168 | 0 | 51,212 | Jan 05 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 05 '26 | Sale | 25.10 | 20,110 | 504,699 | 31,212 | Jan 05 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 06 '25 | Option Exercise | 0.00 | 37,166 | 0 | 34,741 | Jan 06 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 06 '25 | Sale | 14.92 | 21,200 | 316,391 | 14,741 | Jan 06 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 08 '24 | Sale | 11.22 | 2,339 | 26,233 | 7,367 | Jan 08 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 05 '24 | Option Exercise | 0.00 | 17,166 | 0 | 17,166 | Jan 08 |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 05 '24 | Sale | 10.65 | 7,460 | 79,465 | 9,706 | Jan 08 |